8-81531264-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4

The NM_001105281.6(FABP12):​c.52G>A​(p.Glu18Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000697 in 1,606,764 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000066 ( 0 hom. )

Consequence

FABP12
NM_001105281.6 missense

Scores

9
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.60
Variant links:
Genes affected
FABP12 (HGNC:34524): (fatty acid binding protein 12) Predicted to enable lipid binding activity. Predicted to be located in cytosol. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3351227).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FABP12NM_001105281.6 linkuse as main transcriptc.52G>A p.Glu18Lys missense_variant 2/5 NP_001098751.1 A6NFH5
FABP12XM_006716465.4 linkuse as main transcriptc.52G>A p.Glu18Lys missense_variant 2/5 XP_006716528.1 A6NFH5
FABP12XM_011517577.3 linkuse as main transcriptc.52G>A p.Glu18Lys missense_variant 3/6 XP_011515879.1 A6NFH5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FABP12ENST00000360464.6 linkuse as main transcriptc.52G>A p.Glu18Lys missense_variant 2/51 ENSP00000353650.4 A6NFH5
FABP12ENST00000692030.1 linkuse as main transcriptc.52G>A p.Glu18Lys missense_variant 3/6 ENSP00000510293.1 A6NFH5
FABP12ENST00000519696.1 linkuse as main transcriptn.4G>A non_coding_transcript_exon_variant 1/45 ENSP00000427973.1 H0YAS1
ENSG00000253374ENST00000523380.5 linkuse as main transcriptn.506-1658C>T intron_variant 5

Frequencies

GnomAD3 genomes
AF:
0.000105
AC:
16
AN:
152158
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000419
AC:
10
AN:
238510
Hom.:
0
AF XY:
0.0000388
AC XY:
5
AN XY:
128810
show subpopulations
Gnomad AFR exome
AF:
0.000206
Gnomad AMR exome
AF:
0.0000299
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000568
Gnomad SAS exome
AF:
0.0000352
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000371
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000660
AC:
96
AN:
1454606
Hom.:
0
Cov.:
29
AF XY:
0.0000637
AC XY:
46
AN XY:
722580
show subpopulations
Gnomad4 AFR exome
AF:
0.000209
Gnomad4 AMR exome
AF:
0.0000227
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000237
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000731
Gnomad4 OTH exome
AF:
0.0000665
GnomAD4 genome
AF:
0.000105
AC:
16
AN:
152158
Hom.:
0
Cov.:
32
AF XY:
0.0000942
AC XY:
7
AN XY:
74324
show subpopulations
Gnomad4 AFR
AF:
0.000362
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000947
Hom.:
0
Bravo
AF:
0.000196
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000270
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000331
AC:
4

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 24, 2024The c.52G>A (p.E18K) alteration is located in exon 1 (coding exon 1) of the FABP12 gene. This alteration results from a G to A substitution at nucleotide position 52, causing the glutamic acid (E) at amino acid position 18 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.27
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.063
T
Eigen
Benign
-0.012
Eigen_PC
Benign
-0.16
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.90
D
M_CAP
Benign
0.056
D
MetaRNN
Benign
0.34
T
MetaSVM
Uncertain
-0.24
T
MutationAssessor
Uncertain
2.8
M
PrimateAI
Benign
0.42
T
PROVEAN
Uncertain
-2.6
D
REVEL
Uncertain
0.33
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0040
D
Polyphen
0.99
D
Vest4
0.32
MVP
0.085
MPC
0.015
ClinPred
0.47
T
GERP RS
3.0
Varity_R
0.45
gMVP
0.60

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs374133627; hg19: chr8-82443499; COSMIC: COSV64617740; COSMIC: COSV64617740; API